Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FCER2 | P06734 | 2/20 | 0.58 |
| ▸ | MMP2 | P08253 | 11/20 | 0.49 |
| ▸ | MMP9 | P14780 | 5/20 | 0.49 |
| ▸ | MMP8 | P22894 | 3/20 | 0.49 |
| ▸ | MMP1 | P03956 | 8/20 | 0.48 |
| ▸ | MMP3 | P08254 | 7/20 | 0.48 |
| ▸ | CTSB | P07858 | 2/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8906170 | 0.81 | CYP1A2 (0.46) | FCER2CTSBCTSSCTSKCTSL | |
| SCHEMBL762206 | 0.81 | FCER2 (0.57) | FCER2MMP2MMP9MMP8MMP1 | |
| SCHEMBL7771309 | 0.79 | GHSR (0.45) | FCER2MMP9MMP8 | |
| SCHEMBL5966507 | 0.75 | CTSS (0.74) | FCER2MMP2MMP9MMP8CTSB | |
| SCHEMBL5557866 | 0.75 | CTSS (0.74) | FCER2MMP2MMP9MMP8CTSB | |
| SCHEMBL8206981 | 0.74 | FCER2 (0.60) | FCER2MMP2MMP9MMP8CTSB | |
| SCHEMBL14748080 | 0.74 | FCER2 (0.55) | FCER2MMP2MMP9MMP8CTSB | |
| SCHEMBL14527604 | 0.74 | CHRNB2 (0.55) | — | |
| SCHEMBL6851903 | 0.73 | FCER2 (1.00) | FCER2MMP2MMP9MMP8MMP1 | |
| SCHEMBL7650106 | 0.72 | FCER2 (0.59) | FCER2MMP2MMP9MMP8MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997023508-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1997-07-03 | — | — | WO | disclosed |